The reachable results in the literature are definitely promising; 18F-FDG PET/CT-based radiomics has the potential to replace classic approaches based on biopsy and histopathology to detect EGFR mutation status in NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.